UK markets closed

IQVIA Holdings Inc. (0JDM.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
248.30+5.26 (+2.17%)
At close: 5:08PM BST
Full screen
Previous close243.03
Open248.29
Bid0.00 x 0
Ask0.00 x 0
Day's range248.29 - 248.29
52-week range248.29 - 248.29
Volume10
Avg. volumeN/A
Market cap49.492B
Beta (5Y monthly)1.45
PE ratio (TTM)118.24
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Consumer Health Apps and Digital Health Tools Proliferate, Improving Quality and Health Outcomes for Patients, Says New Report from IQVIA Institute

    RESEARCH TRIANGLE PARK, N.C., July 22, 2021--Digital health tools are increasingly having a positive impact on health outcomes. Some are becoming integral parts of mainstream medicine, according to findings released today by the IQVIA Institute for Human Data Science in a new report, Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption.

  • Business Wire

    IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021

    RESEARCH TRIANGLE PARK, N.C., July 13, 2021--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its second-quarter 2021 financial results before the market opens on Tuesday, July 27, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

  • Business Wire

    IQVIA Launches the Clinical Data Analytics Suite (CDAS) to Enable Smarter, Faster Clinical Trials

    RESEARCH TRIANGLE PARK, N.C., June 24, 2021--IQVIA™ (NYSE: IQV) today introduced Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and unstructured data from clinical trials into a single, standardized setting for easier access and use. This produces a scalable repository, that helps meet regulatory requirements, for stakeholders to investigate operational and clinical data. It also drives faster predictive analytics using AI/ML, ena